1129 results found.
                    
Company Revenue 2016
Here is our final look at 2016 revenue.  Exhibit 1: Orthopaedic Sales, As-Reported: 2016 vs. 201...
Top 5 Orthopaedic Players Post Revenue Growth
Combined, the top five largest players in orthopaedics posted 2016 revenue of US $28.6BB, up $671.7MM or +2.4% vs. ...
Alphatec Announces $18.9 Million Private Placement
Alphatec Spine entered into a definitive securities purchase agreement to raise ~US $18.9MM in a private placement
Study Results: Rotation Medical Bioinductive Implant in Rotator Cuff Tears
Study results indicate that Rotation Medical's collagen-based Bioinductive Implant induced new tissue f...
Study Results: Mesoblast’s Cell Therapy in Degenerative Disc Disease
Studies suggest that a single injection of Mesenchymal Precursor Cells resulted in meaningful improvements in chronic lo...
Xtant Medical Posts 4Q16 and 2016 Revenue
Xtant Medical posted 2016 revenue of US $90.0MM, +4.0% vs. 2015, with 4Q16 revenue of $24.5MM, +9.9% v...
Vericel Posts 4Q16 and 2016 Revenue
Vericel posted 2016 Carticel revenue of US $38.8MM, +10.2% vs. 2015, with 4Q16 revenue of $12.7MM, +12.4% vs...
BONESUPPORT Extends U.S. Distribution Agreement with Zimmer Biomet for CERAMENT
BONESUPPORT extended its U.S. distribution agreement with Zimmer Biomet (ZBH), continuing ZBH's exclusiv...
Strategic orthopaedic-related 510(k)s issued in February 2017
Strategic orthopaedic-related 510(k)s issued in February 2017 include: NanoFuse (Amend Surgical*), Arrowhead Mini-Rail Fixator (Arrowhead
FDA 510(k) Clearance for Kyphon Xpede Bone Cement
Medtronic received FDA 510(k) clearance of Kyphon™ Xpede Bone Cement for fixation of pathological
First Fibroblast Injection in Trial for Spinal Disc Regeneration
SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc reg...
Amend Surgical Enters Agreement with UFRF for Biomimetic Bone Development
Amend Surgical entered into an exclusive agreement with The University of Florida Research Foundation to
Vericel Company Profile
A continuously updated record of Vericel's financials and strategic events throughout the year.    Financials ($MM)* Quarterly
Recruitment Status for ALLOB Delayed-Union Study
Bone Therapeutics completed recruitment of 16 patients in the Phase I/IIA delayed-union fracture study of ALLOB...
Positive Interim Data from Trial for BonyPid Antibiotic Eluting Bone Substitute
Interim results from study of BonyPid®-1000 bone substitute in the treatment of open tibial fractures
Second Patent for TheraCell Demineralized Bone Fiber Technology
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled
SeaSpine Reports 4Q16 and 2016 Revenue
SeaSpine announced 2016 revenue of US $128.9MM, -3.2% vs. 2015, with 4Q16 revenue of $32.5MM, -6.5% vs. 4...
K2M Reports 4Q16 and 2016 Revenue
K2M posted 2016 revenue of US $236.6MM, +9.6% vs. 2015, with 4Q16 revenue of $61.8MM, +14.0% vs. 4Q15.
Bioactive Glass Shown Effective Towards Antibiotic-resistant Bacteria
Studies of BonAlive® indicate that the naturally-antibacterial bioactive glass yields excellent results in the...
Study Results: Vitrium Bioactive Glass in Ovine Spinal Fusion
Results from ovine study of Bio2 Technologies' Vitrium bioactive glass demonstrated the device's capability to
K2M Company Profile
A continuously updated record of K2M's financials and strategic events throughout the year. Revenue reflects ORTHOWORLD estimates.   Financials ($MM)* Quarterly
FDA 510(k) Clearance for NanoFUSE BA
Amend Surgical received FDA 510(k) clearance to market NanoFUSE® BA as a bone graft extender for s...
SeaSpine Company Profile
A continuously updated record of SeaSpine's financials and strategic events throughout the year. Revenue reflects ORTHOWORLD estimates.   Financials ($MM)* Quarterly
Orthofix Reports 4Q16 and 2016 Revenue
Orthofix posted 2016 revenue of US $409.8MM, +3.4% from 2015, with 4Q16 revenue of $108.5MM, +3.7% vs. 4...
Globus Medical Posts 4Q16 and 2016 Revenue
Globus Medical posted 2016 revenue of US $564.0MM, +3.5% vs. 2015, with 4Q16 revenue of $151.6MM, +6.3%
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2017 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group